Clincosm LogoSign in Get a demo

major depressive disorder

Showing NaN - NaN of 75
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDD Trial in United States (REL-1017)

Recruiting
  • Major Depressive Disorder
  • Saraland, Alabama
  • +102 more
Jan 18, 2023

MDD Trial in United States (SAGE-217, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Rogers, Arkansas
  • +52 more
Nov 22, 2022

Migraine, MDD Trial in Worldwide (Fremanezumab, Placebo)

Completed
  • Migraine
  • Major Depressive Disorder
  • Little Rock, Arkansas
  • +63 more
Dec 7, 2022

MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)

Completed
Has Results
  • Major Depressive Disorder
  • +2 more
  • AXS-05 (dextromethorphan and bupropion) oral tablets
  • Phoenix, Arizona
  • +50 more
Sep 16, 2022

MDD Trial in Australia, United States (10 mg PRAX-114, 20 mg PRAX-114, 40 mg PRAX-114)

Completed
  • Major Depressive Disorder
  • 10 mg PRAX-114
  • +4 more
  • Lafayette, California
  • +23 more
Aug 18, 2022

MDD Trial in Australia, United States (PRAX-114, Placebo)

Completed
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +30 more
Jul 20, 2022

MDD Trial in United States (SP-624, Placebo)

Active, not recruiting
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +38 more
May 13, 2022

MDD Trial in United States (REL-1017, Placebo)

Recruiting
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +57 more
May 9, 2022

MDD Trial in United States (REL-1017, Placebo)

Recruiting
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +52 more
Apr 14, 2022

MDD Trial in United States (BTRX-335140, Placebo)

Active, not recruiting
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +37 more
Mar 11, 2022

MDD Trial in United States (SAGE-217, Placebo)

Terminated
  • Major Depressive Disorder
  • Bentonville, Arkansas
  • +45 more
Oct 15, 2021

Depression, MDD Trial in United States (AXS-05, Placebo)

Completed
  • Depression
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +42 more
Sep 22, 2021

MDD Trial in Worldwide (SPD489 (Lisdexamfetamine dimesylate) + Antidepressant)

Terminated
Has Results
  • Major Depressive Disorder
  • SPD489 (Lisdexamfetamine dimesylate) + Antidepressant
  • Birmingham, Alabama
  • +211 more
Jun 9, 2021

MDD Trial in United States (BTRX-246040 oral capsule(s), Placebo oral capsule(s))

Completed
Has Results
  • Major Depressive Disorder
  • BTRX-246040 oral capsule(s)
  • Placebo oral capsule(s)
  • Cerritos, California
  • +7 more
Apr 19, 2021

MDD Trial in Australia, Puerto Rico, United States (ALKS 5461, ALKS 5461 Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • ALKS 5461 Placebo
  • Tucson, Arizona
  • +34 more
Mar 15, 2021

MDD Trial in United States (Vortioxetine, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • Phoenix, Arizona
  • +78 more
Dec 16, 2020

MDD Trial in Puerto Rico, United States (AGO178)

Terminated
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +97 more
Dec 16, 2020

MDD Trial in Puerto Rico, United States (Agomelatine (AGO178C), Placebo)

Completed
  • Major Depressive Disorder
  • Agomelatine (AGO178C)
  • Placebo
  • Birmingham, Alabama
  • +44 more
Dec 16, 2020

MDD Trial in United States (agomelatine, )

Completed
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +77 more
Dec 15, 2020

MDD Trial in United States (Assay-guided treatment (AGT), Treatment-as-usual (TAU))

Completed
Has Results
  • Major Depressive Disorder
  • Assay-guided treatment (AGT)
  • Treatment-as-usual (TAU)
  • Birmingham, Alabama
  • +22 more
Aug 27, 2020

Depression, MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)

Completed
Has Results
  • Depression
  • Major Depressive Disorder
  • Levomilnacipran ER
  • Placebo
  • Beverly Hills, California
  • +34 more
Dec 23, 2019

MDD Trial in United States (Placebo, Vilazodone)

Completed
Has Results
  • Major Depressive Disorder
  • Imperial, California
  • +51 more
Dec 6, 2019

MDD Trial in Canada, United States (Vilazodone)

Completed
Has Results
  • Major Depressive Disorder
  • Birmingham, Alabama
  • +55 more
Sep 10, 2019

MDD Trial in Worldwide (ALKS 5461, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Placebo
  • Birmingham, Alabama
  • +43 more
Aug 2, 2019

MDD Trial in Bulgaria, United States (ALKS 5461, Placebo)

Completed
Has Results
  • Major Depressive Disorder
  • ALKS 5461
  • Placebo
  • Little Rock, Arkansas
  • +57 more
May 31, 2019